Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters

P Richtrova, K Jr Opatrny, L Vit, F Sefrna, R Perlik

. 2007 ; 22 (10) : 2978-2984.

Jazyk angličtina Země Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc10026372
E-zdroje Online

NLK Free Medical Journals od 1996 do Před 1 rokem
Open Access Digital Library od 1996-01-01

BACKGROUND: Thrombogenicity is an important parameter of haemodialysis (HD) membrane biocompatibility. The surface of the polyacrylonitrile AN69 ST membrane is coated with a polyethylenimine. This modification allows heparin adsorption. The binding of heparin to the membrane surface occurs during priming of the extracorporeal circuit (ECC) by rinsing it with saline and heparin. Our aims were to assess and compare the thrombogenicity of the AN69 ST membrane under conditions of two extracorporeal circuit (ECC) rinse protocols-with and without unfractionated heparin (UFH). METHODS: In a prospective, crossover and randomized study, we examined 10 patients during HD after ECC preparation with either rinse protocols. Prior to HD and at 15, 60 and 240 min, we determined plasma levels of the thrombin-antithrombin complexes (TAT), platelet factor 4 (PF4), heparin concentration (antiXa) and thrombocyte count. Systemic anticoagulation was performed using UFH. RESULTS: During HD after ECC rinse without UFH, there was a significantly earlier and more marked increase in TAT compared with UFH-containing rinse (P <0.05). Using Spearman coefficient, we demonstrated a significant correlation between TAT and antiXa at 60 min (r = -0.534) and 240 min (r = -0.538). A comparison of the TAT/antiXa ratios between rinses at 60 min revealed a significantly higher increase in TAT following UFH-free rinse (P <0.05). There was no difference in PF4 between the rinses. Platelet count did not change significantly during HD using either rinse protocol. CONCLUSION: Based on plasma TAT levels, ECC priming with an UFH-containing solution reduces the thrombogenicity of the AN69 ST membrane. There is no significant difference between both types of priming concerning PF4 and thrombocyte count.

000      
00000naa 2200000 a 4500
001      
bmc10026372
003      
CZ-PrNML
005      
20111210192331.0
008      
101018s2007 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Richtrová, Pavlína, $d 1975- $7 xx0074467
245    14
$a The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters / $c P Richtrova, K Jr Opatrny, L Vit, F Sefrna, R Perlik
314    __
$a Department of Internal Medicine I, Charles University, Medical School and Teaching Hospital, Alej Svobody 80, 30460 Plzen, Czech Republic. richtrovap@fnplzen.cz
520    9_
$a BACKGROUND: Thrombogenicity is an important parameter of haemodialysis (HD) membrane biocompatibility. The surface of the polyacrylonitrile AN69 ST membrane is coated with a polyethylenimine. This modification allows heparin adsorption. The binding of heparin to the membrane surface occurs during priming of the extracorporeal circuit (ECC) by rinsing it with saline and heparin. Our aims were to assess and compare the thrombogenicity of the AN69 ST membrane under conditions of two extracorporeal circuit (ECC) rinse protocols-with and without unfractionated heparin (UFH). METHODS: In a prospective, crossover and randomized study, we examined 10 patients during HD after ECC preparation with either rinse protocols. Prior to HD and at 15, 60 and 240 min, we determined plasma levels of the thrombin-antithrombin complexes (TAT), platelet factor 4 (PF4), heparin concentration (antiXa) and thrombocyte count. Systemic anticoagulation was performed using UFH. RESULTS: During HD after ECC rinse without UFH, there was a significantly earlier and more marked increase in TAT compared with UFH-containing rinse (P <0.05). Using Spearman coefficient, we demonstrated a significant correlation between TAT and antiXa at 60 min (r = -0.534) and 240 min (r = -0.538). A comparison of the TAT/antiXa ratios between rinses at 60 min revealed a significantly higher increase in TAT following UFH-free rinse (P <0.05). There was no difference in PF4 between the rinses. Platelet count did not change significantly during HD using either rinse protocol. CONCLUSION: Based on plasma TAT levels, ECC priming with an UFH-containing solution reduces the thrombogenicity of the AN69 ST membrane. There is no significant difference between both types of priming concerning PF4 and thrombocyte count.
650    _2
$a akrylové pryskyřice $x chemie $7 D000180
650    _2
$a adsorpce $7 D000327
650    _2
$a senioři $7 D000368
650    _2
$a biokompatibilní materiály $7 D001672
650    _2
$a trombocyty $x metabolismus $7 D001792
650    _2
$a klinické křížové studie $7 D018592
650    _2
$a design vybavení $7 D004867
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hemodialyzační roztoky $x chemie $7 D015312
650    _2
$a heparin $x chemie $7 D006493
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a trombocytový faktor 4 $x chemie $7 D010978
650    _2
$a prospektivní studie $7 D011446
650    _2
$a dialýza ledvin $x metody $x přístrojové vybavení $7 D006435
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a trombóza $7 D013927
650    _2
$a časové faktory $7 D013997
650    _2
$a financování organizované $7 D005381
650    _2
$a randomizované kontrolované studie jako téma $7 D016032
700    1_
$a Opatrný, Karel, $d 1954-2006 $7 nlk19990073633
700    1_
$a Vít, Ladislav, $d 1962- $7 xx0138815
700    1_
$a Šefrna, František. $7 xx0179993
700    1_
$a Perlík, Radek $7 xx0142913
773    0_
$w MED00010288 $t Nephrology, dialysis, transplantation $g Roč. 22, č. 10 (2007), s. 2978-2984 $x 0931-0509
910    __
$a ABA008 $b x $y 7
990    __
$a 20110112131936 $b ABA008
991    __
$a 20110117105730 $b ABA008
999    __
$a ok $b bmc $g 801477 $s 666224
BAS    __
$a 3
BMC    __
$a 2007 $b 22 $c 10 $d 2978-2984 $i 0931-0509 $m Nephrology, dialysis, transplantation $n Nephrol Dial Transplant $x MED00010288
LZP    __
$a 2010-B/mk

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...